Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-07

Clinical Trial Update: Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing the efficacy and safety of a ketorolac/pitofenone/fenpiverinium regimen for postsurgical pain after abdominal and pelvic operations ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac / Pitofenone / Fenpiverinium

Snippet

Sponsor: Darnitsa Pharmaceutical Company | Conditions: Postsurgical Pain | Phase 2, Phase 3 | Status: COMPLETED